https://www.indianpharmapost.com/zydus-lifesciences-subsidiary-sentynl-acquires-bridgebios-nulibry-115502022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/novartis-voyager-therapeutics-reach-license-deal-for-gene-therapy-vectors-to-combat-neurological-diseases-115632022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/philips-mobile-cardiac-outpatient-telemetry-detects-atrial-fibrillation-early-115622022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-expands-research-collaboration-for-biologic-medicines-115612022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-partners-with-indian-society-of-nephrology-to-promote-kidney-health-115602022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/indian-pharma-market-growth-flat-in-feb-2022-115592022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/srl-diagnostics-report-indicates-women-neglect-routine-tests-115582022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/who-global-centre-for-traditional-medicine-to-come-up-in-jamnagar-115572022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/venus-remedies-wins-who-gdp-certification-115562022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-andreas-amrein-joins-advanced-clinical-to-lead-expansion-in-apac-europe-and-canada-115552022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/alvotech-settles-with-abbvie-to-secure-us-rights-to-humira-biosimilar-115542022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/openeye-scientific-and-gaussian-collaboration-expands-quantum-chemistry-calculations-115532022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-evoke-spinal-cord-stimulation-system-115522022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/alkido-pharma-and-cedars-sinai-enter-master-collaboration-agreement-115512022-03-09T00:00:00+05:30always0.9https://www.indianpharmapost.com/siis-covovax-approved-for-12-17-years-age-group-115652022-03-09T00:00:00+05:30always0.9